smhealthcomreports.blogspot.com
Payer Markets Access and Reimbursement
http://smhealthcomreports.blogspot.com/2015/01/biosimilars-timeof-reckoning-has.html
Payer Markets Access and Reimbursement. An educational blog about reaching payer markets and ensuring access, coverage, and reimbursement for pharmaceuticals, medical devices, and diagnostics. Wednesday, January 7, 2015. Biosimilars: A Time of Reckoning Has Arrived. Stanton R. Mehr, President, SM Health Communications LLC. On Wednesday January 8. SM Health Communications provides writing, consulting, and innovative market research services for the payer markets. Its proprietary P&T Insight™ vir...Simple ...
smhealthcomreports.blogspot.com
Payer Markets Access and Reimbursement: June 2014
http://smhealthcomreports.blogspot.com/2014_06_01_archive.html
Payer Markets Access and Reimbursement. An educational blog about reaching payer markets and ensuring access, coverage, and reimbursement for pharmaceuticals, medical devices, and diagnostics. Wednesday, June 18, 2014. Biosimilars Looming on the Horizon: How Will Payers React? Stanton R. Mehr, President, SM Health Communications LLC. Does this mean that aggressive contracting can save the day for the innovator products? 1 Does your organization have a plan for addressing biosimilar launches in the rheuma...
smhealthcomreports.blogspot.com
Payer Markets Access and Reimbursement: A Postmarketing Surveillance Effort for New Biosimilar Agents
http://smhealthcomreports.blogspot.com/2015/01/a-postmarketing-surveillance-effort-for.html
Payer Markets Access and Reimbursement. An educational blog about reaching payer markets and ensuring access, coverage, and reimbursement for pharmaceuticals, medical devices, and diagnostics. Tuesday, January 20, 2015. A Postmarketing Surveillance Effort for New Biosimilar Agents. Stanton R. Mehr, President, SM Health Communications LLC. In November 2013, the Academy of Managed Care Pharmacy hosted a Task Force conference discussing the highly anticipated approval process for new biosimilar agents and h...
smhealthcomreports.blogspot.com
Payer Markets Access and Reimbursement: July 2013
http://smhealthcomreports.blogspot.com/2013_07_01_archive.html
Payer Markets Access and Reimbursement. An educational blog about reaching payer markets and ensuring access, coverage, and reimbursement for pharmaceuticals, medical devices, and diagnostics. Friday, July 26, 2013. The Technology Assessment Committee: Coverage Decision Making for the Medical Benefit. R Mehr, President, SM Health Communications, Valley Cottage, NY. Health technology assessment describes the evaluation performed by informed professionals to decide on the safety, efficacy, effectiveness, a...
smhealthcomreports.blogspot.com
Payer Markets Access and Reimbursement: April 2014
http://smhealthcomreports.blogspot.com/2014_04_01_archive.html
Payer Markets Access and Reimbursement. An educational blog about reaching payer markets and ensuring access, coverage, and reimbursement for pharmaceuticals, medical devices, and diagnostics. Thursday, April 17, 2014. Demonstrating Specialty Pharmaceutical Value and an Opportunity to Meet the Challenge. By Stanton R. Mehr. President, SM Health Communications. I used the term cost nightmare. How much can patients afford to pay? Is 20% of a therapy that costs $2,500 each month reasonable? As of March 31, ...
smhealthcomreports.blogspot.com
Payer Markets Access and Reimbursement: September 2013
http://smhealthcomreports.blogspot.com/2013_09_01_archive.html
Payer Markets Access and Reimbursement. An educational blog about reaching payer markets and ensuring access, coverage, and reimbursement for pharmaceuticals, medical devices, and diagnostics. Tuesday, September 3, 2013. The 5 Critical Features of an Excellent Payer Market Research Network. R Mehr, President, SM Health Communications LLC. 1) The ability to get them to answer your call. 2) The size and variability of the network. 3) Solid relationships with the consultant community. Also of importance is ...
smhealthcomreports.blogspot.com
Payer Markets Access and Reimbursement: July 2015
http://smhealthcomreports.blogspot.com/2015_07_01_archive.html
Payer Markets Access and Reimbursement. An educational blog about reaching payer markets and ensuring access, coverage, and reimbursement for pharmaceuticals, medical devices, and diagnostics. Wednesday, July 29, 2015. Pharmaceutical Pricing: Real Value vs. Revenue Forecasting. Stanton R. Mehr, President, SM Health Communications LLC. As it turned out, Gilead’s concept of real value was reconsidered under threats from major PBMs to exclude coverage, in favor of AbbVie’s competitor product. Well, no, said...
smhealthcomreports.blogspot.com
Payer Markets Access and Reimbursement: Pharmaceutical Pricing: Real Value vs. Revenue Forecasting
http://smhealthcomreports.blogspot.com/2015/07/pharmaceutical-pricing-real-value-vs.html
Payer Markets Access and Reimbursement. An educational blog about reaching payer markets and ensuring access, coverage, and reimbursement for pharmaceuticals, medical devices, and diagnostics. Wednesday, July 29, 2015. Pharmaceutical Pricing: Real Value vs. Revenue Forecasting. Stanton R. Mehr, President, SM Health Communications LLC. As it turned out, Gilead’s concept of real value was reconsidered under threats from major PBMs to exclude coverage, in favor of AbbVie’s competitor product. Well, no, said...
smhealthcomreports.blogspot.com
Payer Markets Access and Reimbursement: March 2014
http://smhealthcomreports.blogspot.com/2014_03_01_archive.html
Payer Markets Access and Reimbursement. An educational blog about reaching payer markets and ensuring access, coverage, and reimbursement for pharmaceuticals, medical devices, and diagnostics. Tuesday, March 18, 2014. Social Context and Payer Market Research. Stanton R. Mehr, President, SM Health Communications LLC. No way. Surveys enhanced by Web distribution and on-line responses (think Survey Monkey. Let’s take this consumer-based approach and apply it to health executives. If there were on-...The res...